Unknown

Dataset Information

0

tert-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity.


ABSTRACT: The structure-activity and structure-kinetic relationships of a new tert-butylphenylthiazole series with oxadiazole linkers were conducted with the objective of obtaining a new orally available antibacterial compounds. Twenty-two new compounds were prepared, purified and identified. Their activity against methicillin-resistant Staphylococcus aureus were examined. Compound 20 with 3-hydroxyazetidine as a nitrogenous side chain showed promising activity against twenty-four clinical isolates, including vancomycin-resistant staphylococcal and enterococcal species with MIC values ranging from 4-8 μg mL-1. Additional advantages of this compound include an ability to eradicate staphylococcal biofilm mass in a dose-dependent manner as well as high metabolic stability after an oral dose of 25 mg kg-1 with a biological half-life that exceeds 5 hours and a plasma concentration (C max) that exceeds the MIC values.

SUBMITTER: Kotb A 

PROVIDER: S-EPMC9061097 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

<i>tert</i>-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity.

Kotb Ahmed A   Abutaleb Nader S NS   Hagras Mohamed M   Bayoumi Ashraf A   Moustafa Mahmoud M MM   Ghiaty Adel A   Seleem Mohamed N MN   Mayhoub Abdelrahman S AS  

RSC advances 20190226 12


The structure-activity and structure-kinetic relationships of a new <i>tert</i>-butylphenylthiazole series with oxadiazole linkers were conducted with the objective of obtaining a new orally available antibacterial compounds. Twenty-two new compounds were prepared, purified and identified. Their activity against methicillin-resistant <i>Staphylococcus aureus</i> were examined. Compound 20 with 3-hydroxyazetidine as a nitrogenous side chain showed promising activity against twenty-four clinical i  ...[more]

Similar Datasets

| S-EPMC6863074 | biostudies-literature
| S-EPMC9884082 | biostudies-literature
| S-EPMC4325764 | biostudies-literature
| S-EPMC5736435 | biostudies-literature
| S-EPMC7549103 | biostudies-literature
| S-EPMC4607640 | biostudies-literature
| S-EPMC7073871 | biostudies-literature
| S-EPMC6440935 | biostudies-literature
| S-EPMC4027551 | biostudies-literature
| S-EPMC2596069 | biostudies-literature